Meeting Banner
Abstract #0508

Diffusion Weighted Imaging Detects Significant Cohort Responses After Seven Days of Treatment with Cediranib in a Phase I Clinical Trial Setting

Matthew R. Orton1, Christina Messiou2, David John Collins1, Veronica A. Morgan2, Dionysis Papadatospastos3, Andre Brunetto3, Jooern Ang3, Helen Mann4, Jean Tessier4, Helen Young4, Stan Kaye3, Johann S. de Bono3, Martin O. Leach1, Nandita M. De Souza1

1CR-UK and EPSRC Cancer Imaging Centre, Institute of Cancer Research, Sutton, Surrey, United Kingdom; 2Radiology Department, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom; 3Department of Medicine, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom; 4AstraZeneca, Macclesfield, Cheshire, United Kingdom

Although DWI measures have previously been reported demonstrating changes with anti-angiogenic agents at 28 days, the response at 7 days has not been widely reported as it is assumed that DWI is insensitive to perfusion changes with an antiangiogenic agent in such a short time-frame. The purpose of this study was to assess changes in DWI derived measures at both 7 and 28 days for a cohort of patients treated with Cediranib. Significant cohort changes are seen at 7 days and these can be detected using a number of diffusion attenuation models, in particular with the stretched-exponential model.

Abstract PDF Presentation Video

Keywords

acquisition activity affecting agent agents although apart appeared assessed assessing assessment association assumed attenuation biological biomedical borderline breathing cancer clearly clinical coefficient cohort combined comparing confidence considered consistent coverage curve dark days decreased decreases define demonstrating derived details detected diffusion disease distributed document dose double drawn england equivalent established evaluate evidenced exponential extending failure falling fitted fitting foundation frame full give good health highlighted hypothesis included indicated indicating influenced inhibitor insignificant intervention jean just kingdom leach least magnitude matrix measure measures mechanism mechanisms median medicine metastatic model mono note offer opportunity optimal outside part partial patient patients patterns percentage performance perfusion plausible population positive potent previously print pure quite radiology received receptors recommended reflecting repeat repeatability reported response royal sensitive setting seven significance simple slices starting statistically status stretched stretching subjects suggests suitable supported suppression surrey system table therapies timing trace treatment trial trust unfortunately unrelated variation vascular veronica volume young